Replies to post #6979 on Cytogenix (fka CYGX)

[grrdvm1]

Paulness..............NICE!

[percywhit]

And TASR split not too long ago. They were over $100/share and then split........and now they have climbed up almost to pre split levels.

"IF" CYGX really is the real McCoy for SEPSIS then we are talking about share prices in the range of TASR.


If the media gets a hold of it it will fly. But we have to get some good proof to give to the national media.

Back to the golf course.

[skoobyfl1]

We are going to get huge monies in from a Sepsis drug, billions & billions. That is one drug & we will have 15+ yrs to milk it. When they get that through, how many other companies are going to stand up & see what else we have to offer. Call it billions more, yearly.

How with that type of earnings potential are we not to continue to rise? We are going to move to a new exchange before years end & with some luck, above a $5 Billion market cap. The math is based on times potential earnings & a good market climate.

Humans will get the Sepsis treatments later this year, it will
work very well. The only thing holding us back now is time, money & regulations. They will all be in line soon enough, get ready.

[JSGatt]

Paulness, thanks for the perspective, and you're right ....

Scooby's projections are "not that far off" depending on how one wants to project.
We must keep in mind that it's all about perception. If we don't capture the imagination of the investing public, the deal unwinds. But if we do, watch out. Then we'll be looking at a few digits in front of the decimal point.

With what I know about the science we have, and the potential for this science in the marketplace, my "guesstimate" is the latter .... big time.

Regards,
~ John

[riched2004]

if they are not way off show me one on the money......

[arnold]

Paulness,

It's great news that down the line CYGX could possibly be $2000 PPS (split adjusted, of course) but any idea when they may hit the $2.00 mark or even stay above the $1 range?

While I'm a long, I also realize that CYGX still has a long way to go in testing to show that their science does work in humans. I truly hope that I am still alive when it hits the $2000 range!

Happy Holiday.

ILENE

[RaptorMan]

I've seen TASR mentioned a couple of times on this board, and frankly, I just don't see how comparing TASR and CYGX is in any way relevant. TASR has a commercial product and CYGX doesn't. TASR's R&D is comparatively cheap, whereas CYGX's is extremely high. TASR doesn't have to go through multiple trials costing millions of dollars in order to get FDA approval, and CYGX does. CYGX is in biotech, and TASR isn't. There just aren't any meaningful points of similarity. It's like comparing GM to Burger King--it just doesn't make sense.